You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
PacBio will try to take the Sequel II to the clinic in China with the help of Berry Genomics and is open to partnerships globally, including with Illumina.
In a retrospective analysis, UK researchers found that long-read sequencing of HLA genes in stem cell transplantation donors and recipients led to better outcomes.
Roche said the timeline to launch a diagnostic system and assays based on PacBio's technology would be too long; instead, it will focus on commercializing Genia's technology.
The two companies struck a $75 million deal in 2013 to launch a sequencing system and assays for the diagnostic market.